(19)
(11) EP 4 561 618 A2

(12)

(88) Date of publication A3:
28.03.2024

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23847294.8

(22) Date of filing: 26.07.2023
(51) International Patent Classification (IPC): 
A61K 39/112(2006.01)
A61P 1/02(2006.01)
A61K 47/36(2006.01)
C12P 19/04(2006.01)
A61K 31/715(2006.01)
A61P 31/04(2006.01)
C07K 14/005(2006.01)
C12R 1/42(2006.01)
(52) Cooperative Patent Classification (CPC):
Y02A 50/30; C07K 14/255; A61K 39/0275; A61P 31/04; A61K 2039/575; A61K 2039/55566; A61K 2039/6075
(86) International application number:
PCT/US2023/028672
(87) International publication number:
WO 2024/025936 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 26.07.2022 US 202263392274 P

(71) Applicants:
  • Board of Trustees of Michigan State University
    East Lansing, MI 48824 (US)
  • University of Maryland, Baltimore
    Baltimore, MD 21201 (US)

(72) Inventors:
  • HUANG, Xuefei
    Okemos, MI 48864 (US)
  • PAN, Xingling
    Lansing, MI 48823 (US)
  • HUO, Chang-Xin
    Lansing, MI 48823 (US)
  • BALIBAN, Scott Michael
    Washington, DC 20003 (US)
  • TENNANT, Sharon Mei
    Ellicott City, MD 21043 (US)

(74) Representative: Hoefer & Partner Patentanwälte mbB 
Pilgersheimer Straße 20
81543 München
81543 München (DE)

   


(54) DEVELOPMENT OF CARBOHYDRATE-BASED ANTI-SALMONELLA VACCINES